One of the most consistent findings in nutritional epidemiology is the association between coffee consumption and lower rates of age-related disease. A new cellular study now offers a concrete molecular explanation for part of that pattern.
Compounds present in brewed coffee bind directly to the orphan nuclear receptor NR4A1 and activate it in laboratory models. The work, carried out at Texas A&M University, demonstrates that this interaction can reduce cell growth in certain cancer lines and dampen inflammatory signalling in immune cells, effects that depend on the presence of the receptor itself.
NR4A1 acts as a stress-inducible and inflammation-inducible nuclear receptor that helps protect tissues from damage. When the receptor is removed from cells, the protective actions of coffee extracts disappear. Stephen Safe, distinguished professor and Sid Kyle Endowed Chair in Veterinary Toxicology at Texas A&M University, put it plainly: "If you damage almost any tissue, NR4A1 responds to bring that damage down. If you take that receptor away, the damage is worse."
Polyphenolics show stronger activity than caffeine
The study tested brewed coffee extracts along with several of its major polyphenolic and polyhydroxy compounds. Caffeic acid, ferulic acid, chlorogenic acid, p-coumaric acid, kahweol and cafestrol all bind to NR4A1 with dissociation constants mostly below 10 micromolar. These substances displayed inverse agonist activity in transactivation assays, altered the expression of NR4A1-responsive genes, and inhibited lipopolysaccharide-induced phosphorylation of IκBα in macrophage cells in a manner consistent with NR4A1 ligand behaviour.
Caffeine and quinic acid also bind to the receptor but produce more variable functional outcomes. Overall the polyphenolic compounds exhibited greater activity on NR4A1 than caffeine itself. The inhibitory effect on cell growth in NR4A1-responsive Rh30 rhabdomyosarcoma cells was attenuated when the receptor was knocked down using RNA interference.
The results of this study demonstrate that brewed coffee and its major polyphenolics and polyhydroxy constituents are NR4A1 ligands and that NR4A1 may play an important role in the health-protective effects of coffee.
Observational data have repeatedly linked coffee intake to lower overall mortality and reduced risk of metabolic disorders, certain cancers, Parkinson’s disease, dementia and cardiovascular conditions. The Texas A&M team suggests NR4A1 may function as a nutrient sensor that detects dietary compounds from coffee and contributes to those protective associations. Yet the researchers are careful to note that their findings come from laboratory cellular models and do not constitute proof of causation in humans.
